Gum – In the Democratic Republic of Congo, a second vaccine is being used to combat the Ebola epidemic that has been rampant for over a year. The product produced for the American Johnson & Johnson vaccine will be used today in Goma, in the east of the country, said Doctors Without Borders (MSF).
Within four months, therefore, 50,000 people should be vaccinated with it. More than 250,000 people have been vaccinated since early August 2018 with a vaccine from the pharmaceutical company Merck. WHO had pushed for the introduction of a second vaccine. She sees this as "potentially an additional means" to prevent the spread of the epidemic.
Ebola erupted in the Congo on August 1, 2018. It is already the tenth epidemic in the country. Above all, the eastern part of the country is affected. In July, WHO declared an international health emergency because of the Ebola epidemic in Congo.
The Ebola virus was first registered in 1976 in the north of the Democratic Republic of Congo and is named after a river in the country. Those affected suffer from fever, muscle aches, diarrhea, internal bleeding and eventually organ failure. © afp / aerzteblatt.de